CLINICAL TRIALS PROFILE FOR EXOSURF NEONATAL
✉ Email this page to a colleague
All Clinical Trials for EXOSURF NEONATAL
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01203358 ↗ | Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome | Completed | NICHD Neonatal Research Network | Phase 2/Phase 3 | 1991-01-01 | The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress syndrome. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EXOSURF NEONATAL
Condition Name
Condition MeSH
| Condition MeSH for EXOSURF NEONATAL | |
| Intervention | Trials |
| Respiratory Distress Syndrome, Newborn | 1 |
| Respiratory Distress Syndrome, Adult | 1 |
| Respiratory Distress Syndrome | 1 |
| Bronchopulmonary Dysplasia | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for EXOSURF NEONATAL
Trials by Country
Clinical Trial Progress for EXOSURF NEONATAL
Clinical Trial Phase
Clinical Trial Sponsors for EXOSURF NEONATAL
Sponsor Name
